Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic, affecting all age groups with a wide spectrum of clinical presentation ranging from asymptomatic to severe interstitial pneumonia, hyperinflammation, and death. Children and infants generally show a mild course of the disease, although infants have been observed to have a higher risk of hospitalization and severe outcomes. Here, we report the case of a preterm infant with a severe form of SARS-CoV-2 infection complicated by cerebral venous thrombosis successfully treated with steroids, hyperimmune plasma, and remdesivir.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Remdesivir, Newborn, cerebral thrombosis, 【초록키워드】 coronavirus disease, pandemic, Hospitalization, SARS-COV-2 infection, Steroids, Infant, outcomes, Hyperimmune plasma, Asymptomatic, hyperinflammation, Venous thrombosis, death, Mild, Coronavirus-2, acute respiratory syndrome, higher risk, severe interstitial pneumonia, Course, responsible, the disease, treated, affecting, all age group, 【제목키워드】 cerebral,
【저자키워드】 COVID-19, SARS-CoV-2, Remdesivir, Newborn, cerebral thrombosis, 【초록키워드】 coronavirus disease, pandemic, Hospitalization, SARS-COV-2 infection, Steroids, Infant, outcomes, Hyperimmune plasma, Asymptomatic, hyperinflammation, Venous thrombosis, death, Mild, Coronavirus-2, acute respiratory syndrome, higher risk, severe interstitial pneumonia, Course, responsible, the disease, treated, affecting, all age group, 【제목키워드】 cerebral,